Leo Pharma to initiate early-stage trial in inflammatory diseases
Leo Pharma is expected to initiate a phase I trial of a new drug candidate named Leo 158969 in February, according to database Clinical Trials.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Extensive layoffs at Leo Pharma – 300 jobs lost
For subscribers